CD200 promotes immunosuppression in the pancreatic tumor microenvironment

BACKGROUND: A significant challenge to overcome in pancreatic ductal adenocarcinoma (PDAC) is the profound systemic immunosuppression that renders this disease non-responsive to immunotherapy. Our supporting data provide evidence that CD200, a regulator of myeloid cell activity, is expressed in the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Choueiry, Fouad, Torok, Molly, Shakya, Reena, Agrawal, Kriti, Deems, Anna, Benner, Brooke, Hinton, Alice, Shaffer, Jami, Blaser, Bradley W, Noonan, Anne M, Williams, Terence M, Dillhoff, Mary, Conwell, Darwin L, Hart, Phil A, Cruz-Monserrate, Zobeida, Bai, Xue-Feng, Carson III, William E, Mace, Thomas A
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Basic Tumor Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7312341/
https://ncbi.nlm.nih.gov/pubmed/32581043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000189
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars